Please use this identifier to cite or link to this item:
|Title:||Angiotensin AT(4) receptors in the normal human prostate and benign prostatic hyperplasia.||Austin Authors:||Dinh, Diem T;Frauman, Albert G ;Casley, David J;Johnston, Colin I;Fabiani, Mark E||Affiliation:||Department of Medicine & Clinical Pharmacology & Therapeutics Unit, Austin & Repatriation Medical Centre, University of Melbourne,. Heidelberg VIC. 3084, Australia||Issue Date:||26-Nov-2001||Publication information:||Molecular and Cellular Endocrinology; 184(1-2): 187-92||Abstract:||The cellular localisation and expression of angiotensin AT(4) receptors was examined in the normal human prostate and benign prostatic hyperplasia (BPH) by quantitative in vitro autoradiography using [(125)I]-Ang IV. In the normal human prostate, AT(4) receptors were localised to the glandular epithelium. Interestingly, specific AT(4) receptor binding was significantly reduced in BPH compared to the normal prostate, as quantitated macroscopically (normal: 5038+/-476 dpm/mm(2), n=6 vs BPH: 2701+/-176 dpm/mm(2), n=6, P<0.001) and microscopically (normal: 7.28+/-0.36 grains/mm(2), n=6 vs BPH: 2.50+/-0.47 grains/mm(2), n=6, P<0.001). The findings of the present study demonstrate the presence of AT(4) receptors in the human prostate, being localised to the glandular epithelium, which suggest that the Ang IV/AT(4) system may play a role in the regulation of ionic transport and glandular secretion in the human prostate. The observation that AT(4) receptors appear reduced in BPH suggests that the AT(4) receptor may undergo agonist-induced receptor internalisation, possibly due to increased local tissue levels of Ang IV in BPH.||Gov't Doc #:||11694354||URI:||http://ahro.austin.org.au/austinjspui/handle/1/9350||URL:||https://pubmed.ncbi.nlm.nih.gov/11694354||Type:||Journal Article||Subjects:||Autoradiography
Iodine Radioisotopes.diagnostic use
|Appears in Collections:||Journal articles|
Show full item record
checked on Dec 2, 2022
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.